UB Paderborn / Katalog / Suche / in CDI

Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission

Clinical and experimental immunology, 2015-08, Vol.181 (2), p.306-313

2015

Volltextzugriff (PDF)

Eculizumab Dosing Regimen in Atypical HUS: Possibilities for Individualized Treatment

Clinical pharmacology and therapeutics, 2017-10, Vol.102 (4), p.671-678

2017

Volltextzugriff (PDF)

Nonresonant Confocal Raman Imaging of DNA and Protein Distribution in Apoptotic Cells

Biophysical journal, 2003-06, Vol.84 (6), p.3968-3981

2003

Volltextzugriff (PDF)

Genotype‐phenotype correlations of low‐frequency variants in the complement system in renal disease and age‐related macular degeneration

Clinical genetics, 2018-10, Vol.94 (3-4), p.330-338

2018

Volltextzugriff (PDF)

Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey

Pediatric nephrology (Berlin, West), 2023-09, Vol.38 (9), p.3035-3042

2023

Volltextzugriff (PDF)

A novel method for direct measurement of complement convertases activity in human serum

Clinical and experimental immunology, 2014-10, Vol.178 (1), p.142-153

2014

Volltextzugriff (PDF)

A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome

Netherlands journal of medicine, 2012-04, Vol.70 (3), p.121-129

2012

Volltextzugriff (PDF)

Eculizumab treatment in pregnancy complicated with APS – Effects on mother and infant

Immunobiology (1979), 2016-10, Vol.221 (10), p.1193-1193

2016

Volltextzugriff (PDF)

Tissue transglutaminase mRNA expression in apoptotic cell death

Apoptosis (London), 2003-12, Vol.8 (6), p.673-679

2003

Volltextzugriff (PDF)

Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS)

Nephrology, dialysis, transplantation, 2010-07, Vol.25 (7), p.2195-2202

2010

Volltextzugriff (PDF)

Shiga toxin induces release of soluble ICAM-1 protein in primary human glomerular microvacular endothelial cells

Molecular immunology, 2013-12, Vol.56 (3), p.278-278

2013

Volltextzugriff (PDF)

Shiga-like toxin upregulates production of C3 mRNA and protein in human endothelial cells

Molecular immunology, 2011-08, Vol.48 (14), p.1686-1686

2011

Volltextzugriff (PDF)

Several genetic aberrations in different complement genes in a patient with dense deposit disease

Molecular immunology, 2011-08, Vol.48 (14), p.1682-1682

2011

Volltextzugriff (PDF)

Novel DNA alterations in FCN1 and FCN2 genes in atypical HUS patients

Molecular immunology, 2011-08, Vol.48 (14), p.1684-1684

2011

Volltextzugriff (PDF)

Mutations in the CFHR5 gene and in genes encoding components of the membrane attack complex in patients with atypical hemolytic uremic syndrome

Molecular immunology, 2011-08, Vol.48 (14), p.1682-1682

2011

Volltextzugriff (PDF)

Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab

Clinical pharmacokinetics, 2019-07, Vol.58 (7), p.859-874

2019

Volltextzugriff (PDF)

Implications of genetic variation in the complement system in age-related macular degeneration

Progress in retinal and eye research, 2021-09, Vol.84, p.100952-100952, Article 100952

2021

Volltextzugriff (PDF)

Mathematical methods application in the risk assessment technologies implementation at oil and gas facilities

Journal of physics. Conference series, 2020-11, Vol.1679 (5), p.52024

2020

Volltextzugriff (PDF)

Application of interactive technologies in organizing training of managers and specialists of the fuel and energy complex in the field of industrial safety

Journal of physics. Conference series, 2020-11, Vol.1691 (1), p.12209

2020

Volltextzugriff (PDF)

Systemic complement levels in patients with age-related macular degeneration carrying rare or low-frequency variants in the CFH gene

Human molecular genetics, 2022-02, Vol.31 (3), p.455-470

2022

Volltextzugriff (PDF)

Development and Implementation of Methods for Behavioral Safety Audit Conducting in the Fuel and Energy Complex

IOP conference series. Earth and environmental science, 2020-04, Vol.459 (3), p.32015

2020

Volltextzugriff (PDF)

Identification of the root causes of accidents at hazardous production facilities of the fuel and energy complex

IOP conference series. Materials Science and Engineering, 2020-12, Vol.976 (1), p.12021

2020

Volltextzugriff (PDF)

Proposal for individualized dosing of eculizumab in atypical haemolytic uraemic syndrome: patient friendly and cost-effective

Nephrology, dialysis, transplantation, 2023-02, Vol.38 (2), p.362-371

2023

Volltextzugriff (PDF)

Accidents and Injury Rates Reduction in Petroleum Industry based on the Development and Implementation of the Automated Complex for the Employees' Professional Competences Assessment

IOP conference series. Earth and environmental science, 2019-06, Vol.272 (3), p.32063

2019

Volltextzugriff (PDF)

Analysis of rare variants in the C3 gene in patients with age-related macular degeneration

PloS one, 2014-04, Vol.9 (4), p.e94165

2014

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission

Eculizumab Dosing Regimen in Atypical HUS: Possibilities for Individualized Treatment

Nonresonant Confocal Raman Imaging of DNA and Protein Distribution in Apoptotic Cells

Genotype‐phenotype correlations of low‐frequency variants in the complement system in renal disease and age‐related macular degeneration

Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey

A novel method for direct measurement of complement convertases activity in human serum

A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome

Eculizumab treatment in pregnancy complicated with APS – Effects on mother and infant

Tissue transglutaminase mRNA expression in apoptotic cell death

Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS)

Shiga toxin induces release of soluble ICAM-1 protein in primary human glomerular microvacular endothelial cells

Shiga-like toxin upregulates production of C3 mRNA and protein in human endothelial cells

Several genetic aberrations in different complement genes in a patient with dense deposit disease

Novel DNA alterations in FCN1 and FCN2 genes in atypical HUS patients

Mutations in the CFHR5 gene and in genes encoding components of the membrane attack complex in patients with atypical hemolytic uremic syndrome

Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab

Implications of genetic variation in the complement system in age-related macular degeneration

Mathematical methods application in the risk assessment technologies implementation at oil and gas facilities

Application of interactive technologies in organizing training of managers and specialists of the fuel and energy complex in the field of industrial safety

Systemic complement levels in patients with age-related macular degeneration carrying rare or low-frequency variants in the CFH gene

Development and Implementation of Methods for Behavioral Safety Audit Conducting in the Fuel and Energy Complex

Identification of the root causes of accidents at hazardous production facilities of the fuel and energy complex

Proposal for individualized dosing of eculizumab in atypical haemolytic uraemic syndrome: patient friendly and cost-effective

Accidents and Injury Rates Reduction in Petroleum Industry based on the Development and Implementation of the Automated Complex for the Employees' Professional Competences Assessment

Analysis of rare variants in the C3 gene in patients with age-related macular degeneration

Suchergebnisse filtern